Skip to main content

Ketamine: A Magic Remedy


Clinical courses


Clinical research courses


Magazine HomeEditorial BoardLatest IssuesAuthor GuidelinesContact Us

June 2018 ARTICLE LIST >>

PharmaTutor (June - 2018)


ISSN: 2347 - 7881
(Volume 6, Issue 6)


Received On: 19/02/2018; Accepted On: 14/05/2018; Published On: 01/06/2018


Kshitij Nuwal*, Shailja Jain, Kamal S Rathore
Department of Pharmacology
B.N. Institute of Pharmaceutical Science,
Udaipur, Rajasthan, India



The largest, longest study conducted on depression treatments, called the STAR*D trial, found that after people tried four antidepressants over the course of five years, about 70% of them were free of depressive symptoms. That’s a lot of trial and error to end at a place where 30% of patients don’t experience remission at all. The STAR*D trial ended in 2014, and despite a clear hole in the market–and a clear patient need–a golden age of new depression treatments still hasn’t arrived. The anesthetic ketamine could offer hope for people who don't have other depression treatment options. The most recent research on ketamine, as well as a statement from experts on its use published in April 2017, finds the drug works quickly, makes dramatic improvements in mood, and can work on people who haven’t gotten better with other depression treatments.



How to cite this article: Nuwal K, Jain S, Rathore KS; Ketamine: A Magic Remedy; PharmaTutor; 2018; 6(6); 24-27;